stock
Abbott Laboratories
NYSE | ABT
132.12
USD
0.00 ( 0.00%)
AT CLOSE (AS OF May 22, 2025)
$231B
MARKET CAP
17.28
P/E Ratio
7.7
EPS
$141
52 Week High
$98
52 Week Low
LIFE SCIENCES
Sector
ABT Chart
Price Action Signals for ABT
Trade Smarter
Automate your trading workflow with powerful tools — built for serious traders.
ABT Technicals
ABT Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $23B |
| Total Revenue | $42B |
| Cost Of Revenue | $19B |
| Costof Goods And Services Sold | $19B |
| Operating Income | $6.8B |
| Selling General And Administrative | $12B |
| Research And Development | $2.8B |
| Operating Expenses | $16B |
| Investment Income Net | - |
| Net Interest Income | -$215M |
| Interest Income | $344M |
| Interest Expense | $559M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.2B |
| Income Before Tax | $7B |
| Income Tax Expense | -$6.4B |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $13B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $7.6B |
| Ebitda | $11B |
| Net Income | $13B |
Revenue & Profitability
Earnings Performance
ABT Financials
yearly Balance Sheet (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Total Assets | $81B |
| Total Current Assets | $24B |
| Cash And Cash Equivalents At Carrying Value | $7.6B |
| Cash And Short Term Investments | $7.6B |
| Inventory | $6.2B |
| Current Net Receivables | $6.9B |
| Total Non Current Assets | $58B |
| Property Plant Equipment | - |
| Accumulated Depreciation Amortization Ppe | - |
| Intangible Assets | $6.6B |
| Intangible Assets Excluding Goodwill | $6.6B |
| Goodwill | $23B |
| Investments | - |
| Long Term Investments | $886M |
| Short Term Investments | $351M |
| Other Current Assets | - |
| Other Non Current Assets | - |
| Total Liabilities | $34B |
| Total Current Liabilities | $14B |
| Current Accounts Payable | $4.2B |
| Deferred Revenue | - |
| Current Debt | - |
| Short Term Debt | $1.5B |
| Total Non Current Liabilities | $19B |
| Capital Lease Obligations | $896M |
| Long Term Debt | $13B |
| Current Long Term Debt | $1.5B |
| Long Term Debt Noncurrent | - |
| Short Long Term Debt Total | $15B |
| Other Current Liabilities | $7.9B |
| Other Non Current Liabilities | $3.4B |
| Total Shareholder Equity | $48B |
| Treasury Stock | - |
| Retained Earnings | $47B |
| Common Stock | $25B |
| Common Stock Shares Outstanding | $1.7B |
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | $8.6B |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $3.2B |
| Capital Expenditures | $2.2B |
| Change In Receivables | - |
| Change In Inventory | -$58M |
| Profit Loss | - |
| Cashflow From Investment | - |
| Cashflow From Financing | -$5.4B |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | $3.8B |
| Dividend Payout Common Stock | $3.8B |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | -$1.3B |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | $13B |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $23B |
| Total Revenue | $42B |
| Cost Of Revenue | $19B |
| Costof Goods And Services Sold | $19B |
| Operating Income | $6.8B |
| Selling General And Administrative | $12B |
| Research And Development | $2.8B |
| Operating Expenses | $16B |
| Investment Income Net | - |
| Net Interest Income | -$215M |
| Interest Income | $344M |
| Interest Expense | $559M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $3.2B |
| Income Before Tax | $7B |
| Income Tax Expense | -$6.4B |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | $13B |
| Comprehensive Income Net Of Tax | - |
| Ebit | $7.6B |
| Ebitda | $11B |
| Net Income | $13B |
Dividends
| Field | Value |
|---|---|
| Ex Dividend Date | 2025-04-15 |
| Declaration Date | 2025-02-21 |
| Record Date | 2025-04-15 |
| Payment Date | 2025-05-15 |
| Amount | 0.59 |
ABT News
ABT Profile
Abbott Laboratories Profile
Sector: LIFE SCIENCES
Industry: PHARMACEUTICAL PREPARATIONS
Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.
PLRZ -20.37%
$0.0043
PTPI -46.45%
$0.0664
NVTS 158.11%
$4.9299
HCTI -17.50%
$0.0066
VHAI 66.67%
$0.0009
QBTS 23.99%
$19.045
GNLN -15.28%
$0.0061
NVDA 1.32%
$133.5407
RGTI 29.55%
$14.1984
PLUG 2.07%
$0.7822
LCID -3.66%
$2.6686
BON 53.57%
$2.15
MLGO 28.61%
$2.0192
IONQ 40.64%
$47.17
TSLA 3.54%
$346.4707
NCNA -5.94%
$0.038
F 0.14%
$10.495
MARA 0.92%
$15.985
AXDX -61.36%
$0.034
RUN -39.45%
$6.455
MULN -0.47%
$0.169
BDRX 8.46%
$1.41
DNN -0.66%
$1.51
GOOGL 2.57%
$172.8988
ATCH 9.82%
$0.2214
PLTR 3.78%
$125.132
SGBX 43.33%
$0.6255
WULF 6.35%
$4.1582
LYT -16.78%
$0.0982
BTOG 8.50%
$0.1723
JWN 0.08%
$24.66
CRWV
-0.78%
$106.55
BITF 2.77%
$1.1099
BTG 2.58%
$3.3133
CLSK -0.69%
$10.04
APLD 11.52%
$7.5612
SOFI 3.52%
$13.25
ITUB 1.05%
$6.7199
BBD 2.92%
$2.82
AGNC 0.06%
$8.8056
AAL 2.00%
$11.465
INTC 0.41%
$20.775
HIMS -3.78%
$55.8079
QUBT 16.03%
$12.23
GOOG 2.23%
$173.86
VIGL 241.77%
$7.895
BTE -1.36%
$1.6079
GNS -3.01%
$0.3637
LAES 10.29%
$3.805
RIOT 1.64%
$8.9854
DGLY -13.67%
$0.0259
DFS -0.21%
$200.05
ASST 48.45%
$11.9357
GRAB 3.69%
$4.9876
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
AAPL -0.02%
$202.05
NEE -7.97%
$65.8385
AMZN 1.43%
$203.99
AES -3.85%
$9.74
CAN 4.59%
$0.715
DGXX -7.59%
$1.34
LUMN 2.24%
$3.8955
LGMK -0.85%
$0.0117
BTBT 6.01%
$2.5654
ACHR 0.00%
$10.82
QXO -1.12%
$16.869
RIG -2.52%
$2.3981
SOUN 4.02%
$9.8507
PFE 0.44%
$23.1412
LYG 1.55%
$4.265
QSI 19.45%
$1.7619
AFMD -34.95%
$0.1815
SMCI 0.26%
$41.7575
ENPH -20.38%
$37.65
VALE 0.73%
$9.72
RIVN -2.29%
$15.965
HBAN 1.08%
$15.485
AMD -0.33%
$111.6909
UNH -1.22%
$299.292
XAGE 23.20%
$3.77
AG -1.35%
$5.8795
ERIC -0.68%
$8.7999
IQ -2.05%
$1.675
HOOD 2.12%
$65.215
PBR -0.17%
$11.89
AAP 52.92%
$47.8799
FNA 0.00%
$13.09
GERN 11.94%
$1.5
SBSW 4.83%
$5.9965
BAC 0.54%
$43.485
NIO -1.27%
$3.89
BERY -2.93%
$67.58
WBD 0.23%
$8.9704
NGD -0.12%
$4.245
IMNN 6.66%
$0.4258
CIFR 2.57%
$3.595
HLN -0.07%
$11.0923
AMCR -1.25%
$9.065
IREN 6.58%
$9.475
PLRZ -20.37%
$0.0043
PTPI -46.45%
$0.0664
NVTS 158.11%
$4.9299
HCTI -17.50%
$0.0066
VHAI 66.67%
$0.0009
QBTS 23.99%
$19.045
GNLN -15.28%
$0.0061
NVDA 1.32%
$133.5407
RGTI 29.55%
$14.1984
PLUG 2.07%
$0.7822
LCID -3.66%
$2.6686
BON 53.57%
$2.15
MLGO 28.61%
$2.0192
IONQ 40.64%
$47.17
TSLA 3.54%
$346.4707
NCNA -5.94%
$0.038
F 0.14%
$10.495
MARA 0.92%
$15.985
AXDX -61.36%
$0.034
RUN -39.45%
$6.455
MULN -0.47%
$0.169
BDRX 8.46%
$1.41
DNN -0.66%
$1.51
GOOGL 2.57%
$172.8988
ATCH 9.82%
$0.2214
PLTR 3.78%
$125.132
SGBX 43.33%
$0.6255
WULF 6.35%
$4.1582
LYT -16.78%
$0.0982
BTOG 8.50%
$0.1723
JWN 0.08%
$24.66
CRWV
-0.78%
$106.55
BITF 2.77%
$1.1099
BTG 2.58%
$3.3133
CLSK -0.69%
$10.04
APLD 11.52%
$7.5612
SOFI 3.52%
$13.25
ITUB 1.05%
$6.7199
BBD 2.92%
$2.82
AGNC 0.06%
$8.8056
AAL 2.00%
$11.465
INTC 0.41%
$20.775
HIMS -3.78%
$55.8079
QUBT 16.03%
$12.23
GOOG 2.23%
$173.86
VIGL 241.77%
$7.895
BTE -1.36%
$1.6079
GNS -3.01%
$0.3637
LAES 10.29%
$3.805
RIOT 1.64%
$8.9854
DGLY -13.67%
$0.0259
DFS -0.21%
$200.05
ASST 48.45%
$11.9357
GRAB 3.69%
$4.9876
ME -21.26%
$0.6063
CUTR -10.19%
$0.0969
AAPL -0.02%
$202.05
NEE -7.97%
$65.8385
AMZN 1.43%
$203.99
AES -3.85%
$9.74
CAN 4.59%
$0.715
DGXX -7.59%
$1.34
LUMN 2.24%
$3.8955
LGMK -0.85%
$0.0117
BTBT 6.01%
$2.5654
ACHR 0.00%
$10.82
QXO -1.12%
$16.869
RIG -2.52%
$2.3981
SOUN 4.02%
$9.8507
PFE 0.44%
$23.1412
LYG 1.55%
$4.265
QSI 19.45%
$1.7619
AFMD -34.95%
$0.1815
SMCI 0.26%
$41.7575
ENPH -20.38%
$37.65
VALE 0.73%
$9.72
RIVN -2.29%
$15.965
HBAN 1.08%
$15.485
AMD -0.33%
$111.6909
UNH -1.22%
$299.292
XAGE 23.20%
$3.77
AG -1.35%
$5.8795
ERIC -0.68%
$8.7999
IQ -2.05%
$1.675
HOOD 2.12%
$65.215
PBR -0.17%
$11.89
AAP 52.92%
$47.8799
FNA 0.00%
$13.09
GERN 11.94%
$1.5
SBSW 4.83%
$5.9965
BAC 0.54%
$43.485
NIO -1.27%
$3.89
BERY -2.93%
$67.58
WBD 0.23%
$8.9704
NGD -0.12%
$4.245
IMNN 6.66%
$0.4258
CIFR 2.57%
$3.595
HLN -0.07%
$11.0923
AMCR -1.25%
$9.065
IREN 6.58%
$9.475
Discover more tools and features to empower your trading
Explore FeaturesQuotes and other market data may be delayed by 15 minutes or more. Financial data is provided by financial exchanges and other content providers and may be delayed as specified by financial exchanges or other data providers. AfterPullback does not verify any data and disclaims any obligation to do so. The information contained on this website is not intended as, and shall not be understood as, financial advice. The website does not operated by attorney, accountant or financial advisor and the information contained on this website is not a substitute for financial advice from a professional who is aware of the facts and circumstances of your individual situation. Nothing available on or through this website should be understood as a recommendation that you should not consult with a financial professional to address your particular information.